John C Reed Selected Research

John C Reed Research Topics

Disease

104	Neoplasms (Cancer) 05/2018 - 02/2002
23	Prostatic Neoplasms (Prostate Cancer) 05/2018 - 07/2002
22	Leukemia 10/2016 - 02/2002
16	Inflammation (Inflammations) 12/2018 - 02/2004
16	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2017 - 02/2002
14	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 11/2004
12	Lymphoma (Lymphomas) 01/2018 - 04/2003
10	Melanoma (Melanoma, Malignant) 01/2014 - 01/2002
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2015 - 03/2003
8	Breast Neoplasms (Breast Cancer) 01/2015 - 03/2002
8	Infections 04/2014 - 01/2002
8	Carcinoma (Carcinomatosis) 02/2013 - 07/2002
8	Carcinogenesis 07/2012 - 11/2002
5	Neoplasm Metastasis (Metastasis) 07/2013 - 05/2004
5	Adenocarcinoma 07/2012 - 02/2004
4	Hematologic Neoplasms (Hematological Malignancy) 10/2017 - 07/2005
4	Huntington Disease (Huntington's Disease) 10/2011 - 12/2005
4	Brain Injuries (Brain Injury) 01/2011 - 05/2003
3	Starvation 01/2018 - 08/2011
3	Splenomegaly 01/2018 - 11/2004
3	Insulin Resistance 10/2016 - 01/2009
3	Necrosis 08/2015 - 05/2002
3	Hypoxia (Hypoxemia) 04/2015 - 12/2003
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2015 - 10/2011
3	Stroke (Strokes) 10/2012 - 08/2004
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2011 - 10/2002
3	Colonic Neoplasms (Colon Cancer) 08/2010 - 08/2005
3	Multiple Myeloma 03/2010 - 05/2008
3	Disease Progression 03/2007 - 12/2005
3	Ischemia 01/2006 - 12/2003
2	Lymphadenopathy 01/2018 - 11/2004
2	Obesity 10/2016 - 02/2010
2	Genetic Translocation (Chromosomal Translocation) 10/2016 - 06/2015
2	Heart Failure 01/2016 - 01/2009
2	Virus Diseases (Viral Diseases) 04/2014 - 12/2008
2	Autoimmune Diseases (Autoimmune Disease) 04/2014 - 01/2004
2	Ovarian Neoplasms (Ovarian Cancer) 02/2013 - 08/2005
2	Alzheimer Disease (Alzheimer's Disease) 10/2012 - 10/2011

Drug/Important Bio-Agent (IBA)

99	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2002
20	CaspasesIBA 04/2013 - 01/2002
12	LigandsIBA 05/2018 - 06/2002
8	CytokinesIBA 10/2016 - 05/2004
8	Death Domain ReceptorsIBA 01/2016 - 03/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 05/2002
7	Peptide Hydrolases (Proteases)FDA Link 10/2009 - 04/2003
6	InflammasomesIBA 12/2018 - 01/2008
6	Caspase 3 (Caspase-3)IBA 09/2014 - 02/2002
6	SurvivinIBA 07/2013 - 06/2003
6	InterleukinsIBA 05/2013 - 06/2003
6	apogossypolIBA 05/2012 - 03/2008
5	OligonucleotidesIBA 01/2017 - 05/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 01/2004
5	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 11/2012 - 05/2010
5	Apoptosis Regulatory ProteinsIBA 10/2012 - 06/2003
5	Caspase 8 (Caspase-8)IBA 01/2011 - 04/2003
4	ABT-737IBA 07/2015 - 06/2005
4	Adenosine Triphosphate (ATP)IBA 01/2014 - 11/2002
4	NucleotidesIBA 02/2013 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 02/2013 - 08/2005
4	TriterpenesIBA 09/2011 - 06/2005
4	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 01/2006
4	AcidsIBA 06/2011 - 06/2005
4	Hormones (Hormone)IBA 01/2011 - 11/2003
4	Peptides (Polypeptides)IBA 11/2008 - 04/2003
4	Caspase 9IBA 04/2008 - 02/2002
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 08/2009
3	AntibodiesIBA 01/2016 - 10/2004
3	TNF-Related Apoptosis-Inducing LigandIBA 01/2016 - 03/2007
3	Small Interfering RNA (siRNA)IBA 01/2014 - 05/2007
3	Inhibitor of Apoptosis ProteinsIBA 01/2014 - 10/2003
3	EnzymesIBA 05/2013 - 05/2007
3	Leucine (L-Leucine)FDA Link 02/2013 - 01/2011
3	NF-kappa B (NF-kB)IBA 01/2013 - 07/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010 - 05/2002
3	Rituximab (Mabthera)FDA Link 04/2010 - 02/2002
3	Monoclonal AntibodiesIBA 01/2010 - 02/2002
3	bardoxoloneIBA 04/2008 - 06/2005
3	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 04/2008 - 06/2005
3	Cytochromes c (Cytochrome c)IBA 03/2008 - 08/2002
3	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2008 - 05/2005
3	PyrinIBA 09/2004 - 07/2003
3	Caspase 1 (ICE Protease)IBA 07/2004 - 07/2003
3	PolyphenolsIBA 01/2004 - 09/2003
2	Toll-Like Receptor AgonistsIBA 01/2018 - 05/2009
2	TNF Receptor-Associated Factor 3IBA 01/2018 - 05/2009
2	AntigensIBA 01/2018 - 05/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2015 - 03/2007
2	navitoclaxIBA 07/2015 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2015 - 12/2003
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2002
2	AD 5IBA 01/2014 - 05/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2013 - 08/2011
2	RNA (Ribonucleic Acid)IBA 02/2013 - 05/2007
2	ParaffinIBA 02/2013 - 01/2010
2	GossypolIBA 11/2012 - 03/2008
2	Glutamic Acid (Glutamate)FDA Link 10/2012 - 10/2011

Therapy/Procedure

36	Therapeutics 01/2018 - 01/2002
13	Drug Therapy (Chemotherapy) 01/2018 - 02/2002
4	Immunotherapy 01/2018 - 12/2003
3	Aftercare (After-Treatment) 07/2002 - 01/2002